These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 4006483)

  • 1. Termination of clinical trials: the beta-blocker heart attack trial and the hypertension detection and follow-up program experience.
    Bell RL; Curb JD; Friedman LM; Payne GH
    Control Clin Trials; 1985 Jun; 6(2):102-11. PubMed ID: 4006483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of visit adherence in the national beta-blocker heart attack trial.
    Bell RL; Curb JD; Friedman LM; McIntyre KM; Payton-Ross C
    Control Clin Trials; 1985 Jun; 6(2):89-101. PubMed ID: 3891227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The beta-blocker heart attack trial. beta-Blocker Heart Attack Study Group.
    JAMA; 1981 Nov; 246(18):2073-4. PubMed ID: 7026815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-blocker heart attack trial: design, methods, and baseline results. Beta-blocker heart attack trial research group.
    Byington RP
    Control Clin Trials; 1984 Dec; 5(4):382-437. PubMed ID: 6151483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results.
    JAMA; 1982 Mar; 247(12):1707-14. PubMed ID: 7038157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Beta Blocker Heart Attack Trial: recruitment experience.
    Goldstein S; Byington R
    Control Clin Trials; 1987 Dec; 8(4 Suppl):79S-85S. PubMed ID: 2894282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mortality in the beta blocker heart attack trial: circumstances surrounding death.
    Peters RW; Byington R; Arensberg D; Friedman LM; Romhilt DW; Barker A; Laubach C; Wilner GW; Goldstein S
    J Chronic Dis; 1987; 40(1):75-82. PubMed ID: 3543049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-Blocker Heart Attack Trial: impact of propranolol therapy on ventricular arrhythmias.
    Morganroth J; Lichstein E; Byington R
    Prev Med; 1985 May; 14(3):346-57. PubMed ID: 3903736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta Blocker Heart Attack Trial: design features.
    Control Clin Trials; 1981 Dec; 2(4):275-85. PubMed ID: 6120793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statistical aspects of early termination in the beta-blocker heart attack trial.
    DeMets DL; Hardy R; Friedman LM; Lan KK
    Control Clin Trials; 1984 Dec; 5(4):362-72. PubMed ID: 6151482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of propranolol on ventricular arrhythmia. The beta-blocker heart attack trial experience.
    Lichstein E; Morganroth J; Harrist R; Hubble E
    Circulation; 1983 Jun; 67(6 Pt 2):I5-10. PubMed ID: 6342839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propranolol therapy in patients with acute myocardial infarction: the Beta-Blocker Heart Attack Trial.
    Goldstein S
    Circulation; 1983 Jun; 67(6 Pt 2):I53-7. PubMed ID: 6342840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized trial of propranolol in patients with acute myocardial infarction. II. Morbidity results.
    JAMA; 1983 Nov; 250(20):2814-9. PubMed ID: 6358542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of prolonged ventricular repolarization following myocardial infarction: the BHAT experience. The BHAT Study Group.
    Peters RW; Byington RP; Barker A; Yusuf S
    J Clin Epidemiol; 1990; 43(2):167-72. PubMed ID: 2406377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Participation in a clinical trial: the patients' point of view.
    Mattson ME; Curb JD; McArdle R
    Control Clin Trials; 1985 Jun; 6(2):156-67. PubMed ID: 4006489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of propranolol in non-Q-wave acute myocardial infarction in the beta blocker heart attack trial.
    Gheorghiade M; Schultz L; Tilley B; Kao W; Goldstein S
    Am J Cardiol; 1990 Jul; 66(2):129-33. PubMed ID: 2196771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of double-blindness at the conclusion of the beta-Blocker Heart Attack Trial.
    Byington RP; Curb JD; Mattson ME
    JAMA; 1985 Mar 22-29; 253(12):1733-6. PubMed ID: 3974051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-blockers after myocardial infarction: influence of first-year clinical course on long-term effectiveness.
    Viscoli CM; Horwitz RI; Singer BH
    Ann Intern Med; 1993 Jan; 118(2):99-105. PubMed ID: 8416325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of propranolol in postinfarction patients with mechanical or electrical complications.
    Furberg CD; Hawkins CM; Lichstein E
    Circulation; 1984 Apr; 69(4):761-5. PubMed ID: 6365352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Beta-blocker Heart Attack Trial.
    Furberg CD
    Z Kardiol; 1985; 74 Suppl 6():159-63. PubMed ID: 2869615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.